Clinic study progress of Hodgkin lymphoma in children and adolescents / 中华实用儿科临床杂志

ABSTRACT

Current 5 -year overall survival rates (OS)for children and adolescents treated for Hodgkin lym-phoma (HL)exceed 90%.However,this early success is negatively impacted by late mortality due to adverse health -related squeal of therapy.This challenge has resulted in the development of various strategies aimed at identifying the optimal balance between maintaining OS and avoidance of long -term morbidity of therapy.With new imaging tech-niques,the success of reducing therapy in a subset of rapid early responders is demonstrated.Treatment strategy is not only a risk -adjusted but also response -based combined -modality therapy.